U.S. flag

An official website of the United States government

NM_000371.4(TTR):c.165G>T (p.Lys55Asn) AND Amyloidosis, hereditary systemic 1

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Oct 13, 2023
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000699004.8

Allele description [Variation Report for NM_000371.4(TTR):c.165G>T (p.Lys55Asn)]

NM_000371.4(TTR):c.165G>T (p.Lys55Asn)

Gene:
TTR:transthyretin [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
18q12.1
Genomic location:
Preferred name:
NM_000371.4(TTR):c.165G>T (p.Lys55Asn)
HGVS:
  • NC_000018.10:g.31592991G>T
  • NG_009490.1:g.6225G>T
  • NM_000371.4:c.165G>TMANE SELECT
  • NP_000362.1:p.Lys55Asn
  • NP_000362.1:p.Lys55Asn
  • LRG_416t1:c.165G>T
  • LRG_416:g.6225G>T
  • LRG_416p1:p.Lys55Asn
  • NC_000018.9:g.29172954G>T
  • NM_000371.3:c.165G>T
Protein change:
K55N
Links:
dbSNP: rs1567945684
NCBI 1000 Genomes Browser:
rs1567945684
Molecular consequence:
  • NM_000371.4:c.165G>T - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Amyloidosis, hereditary systemic 1 (AMYLD1)
Synonyms:
Amyloidosis Transthyretin related; Amyloid polyneuropathy transthyretin related; Transthyretin amyloidosis; See all synonyms [MedGen]
Identifiers:
MONDO: MONDO:0971004; MedGen: C2751492; Orphanet: 85447; Orphanet: 85451; OMIM: 105210

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000827696Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Pathogenic
(Oct 13, 2023)
germlineclinical testing

PubMed (5)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Familial amyloid polyneuropathy in Korea: the first case report with a proven ATTR Lys35Asn gene.

Ryu JK, Baik HW, Bae JS, Hwang TJ, Paik SY, Yu HJ, Choi BO, Takei Y, Ikeda S.

Amyloid. 2005 Mar;12(1):62-4.

PubMed [citation]
PMID:
16076613

Diflunisal stabilizes familial amyloid polyneuropathy-associated transthyretin variant tetramers in serum against dissociation required for amyloidogenesis.

Tojo K, Sekijima Y, Kelly JW, Ikeda S.

Neurosci Res. 2006 Dec;56(4):441-9. Epub 2006 Oct 6.

PubMed [citation]
PMID:
17028027
See all PubMed Citations (5)

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV000827696.5

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (5)

Description

This sequence change replaces lysine, which is basic and polar, with asparagine, which is neutral and polar, at codon 55 of the TTR protein (p.Lys55Asn). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with clinical features of hereditary transthyretin-mediated amyloidosis (hATTR amyloidosis) (PMID: 16076613, 17028027, 19467548). This variant is also known as Lys35Asn. ClinVar contains an entry for this variant (Variation ID: 576496). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt TTR protein function. This variant disrupts the p.Lys55 amino acid residue in TTR. Other variant(s) that disrupt this residue have been observed in individuals with TTR-related conditions (PMID: 21843040; Invitae), which suggests that this may be a clinically significant amino acid residue. For these reasons, this variant has been classified as Pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024